Lupin strengthens on getting CCEA’s nod to raise FII limit

29 Jan 2015 Evaluate

Lupin is currently trading at Rs. 1534.55, up by 21.20 points or 1.40 % from its previous closing of Rs. 1513.35 on the BSE.

The scrip opened at Rs. 1532.00 and has touched a high and low of Rs. 1539.00 and Rs. 1520.55 respectively. So far 27903 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1539.00 on 29-Jan-2015 and a 52 week low of Rs. 855.00 on 30-Jan-2014.

Last one week high and low of the scrip stood at Rs. 1539.00 and Rs. 1473.25 respectively. The current market cap of the company is Rs. 68487.15 crore.

The promoters holding in the company stood at 46.66% while Institutions and Non-Institutions held 42.51% and 10.83% respectively.

The Cabinet Committee on Economic Affairs (CCEA) has approved pharmaceutical major Lupin’s proposal to raise the foreign institutional investment limit to 49% from 33%. With this, the company is expected to attract Rs 6,099 crore.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment.

 

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×